Celltrion Healthcare receives positive CHMP opinion for subcutaneous formulation of infliximab, Remsima® SC, for direct use of subcutaneous therapy without IV loading in adults with rheumatoid arthritis
The Committee for Medicinal Products for Human Use (CHMP) recommends that Remsima® SC can be initiated without IV loading in...







